Gov. Abigail Spanberger on Monday signed a package of economic development bills aimed at securing billions of dollars in ...

Gov. Abigail Spanberger signed into law on Monday four pieces of legislation that solidify deals Glenn Youngkin made with ...

While the opioid epidemic is one of the most urgent public health emergencies facing the U.S., new therapeutic approaches for treating the underlying substance use disorder have lagged far behind. | ...

In February, a small biotech company reached a breakthrough with the FDA, agreeing to a clinical trial plan. The problem: The ...

A new pill called baxdrostat is showing strong results in lowering dangerously high blood pressure in people who don’t respond to standard treatments. In a large global trial, patients saw their blood ...

For the millions of people who carry the gene APOE4, the strongest known genetic risk factor for Alzheimer's disease, their ...

The 2026 Government Work Report identified biopharmaceuticals as an emerging pillar industry for the first time, placing it ...

Transitioning from a disposable, prefilled autoinjector to a reusable pen meant designing for an even better experience.

AstraZeneca has reported positive results from the efzimfotase alfa Phase III clinical trial programme for hypophosphatasia ...

Life sciences companies like DFW because it offers easy access to utilities, an abundance of available land and less ...

Drugmaker Merck said on Monday its oral drug met the main goal of meaningfully reducing bad cholesterol in a late-stage ...

The FDA has some big verdicts lined up in the second quarter, including one for a closely watched obesity drug that many anticipate will further intensify competition in weight loss.